Chiara Carcieri
A. O. Ordine Mauriziano di Torino(IT)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV/AIDS Research and Interventions, HIV Research and Treatment, Antifungal resistance and susceptibility
Most-Cited Works
- → A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma(2016)125 cited
- → Cannabinoids concentration variability in cannabis olive oil galenic preparations(2017)63 cited
- → Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children(2017)56 cited
- → UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma(2017)51 cited
- → Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms(2014)41 cited
- → Pharmacogenetic of Voriconazole Antifungal Agent in Pediatric Patients(2018)33 cited
- → A LC–MS method to quantify tenofovir urinary concentrations in treated patients(2015)26 cited
- → Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children(2017)21 cited
- → Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection(2017)19 cited
- → Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure(2017)14 cited